Markets News

Latest stock market news and real-time market analysis. Track S&P 500, Nasdaq, and Dow Jones movements, sector rotations, and breaking market events.

Nu Holdings Stock Rebounds as Investors Eye Credit Risks Amid Record Revenue
Markets Daniel Marsh

Nu Holdings Stock Rebounds as Investors Eye Credit Risks Amid Record Revenue

Nu Holdings shares rose 2.3% to $12.58, rebounding after earnings as Nubank's record revenue was offset by rising credit loss allowances and delinquencies.

NU
Wall Street Edges Higher as Chip Stocks Rally Ahead of Nvidia's Earnings
Markets Daniel Marsh

Wall Street Edges Higher as Chip Stocks Rally Ahead of Nvidia's Earnings

U.S. stocks edged higher Wednesday, led by chip stocks ahead of Nvidia's earnings. The S&P 500 rose 0.18% while oil prices fell.

NVDA MRVL INTC MU TJX TGT LOW INTU
Blue Chips Rebound 200 Points as Nvidia Earnings, Fed Minutes Loom
Markets Daniel Marsh

Blue Chips Rebound 200 Points as Nvidia Earnings, Fed Minutes Loom

The Dow Jones Industrial Average climbed 209 points to 49,573, rebounding from Tuesday's decline, as markets eye Nvidia's earnings and Fed minutes.

GS BA NVDA MRVL INTC MU
Carnival Stock Recovers as Dividend, Fuel Costs and Restructuring Draw Attention
Markets Daniel Marsh

Carnival Stock Recovers as Dividend, Fuel Costs and Restructuring Draw Attention

Carnival shares edged higher Wednesday, recovering from Tuesday's decline, as the market evaluates its dividend timeline, recent corporate simplification, and lingering fuel-cost exposure.

CCL RCL NCLH
Mister Car Wash Exits Nasdaq After $3.1B Take-Private by Leonard Green
Markets Daniel Marsh

Mister Car Wash Exits Nasdaq After $3.1B Take-Private by Leonard Green

Mister Car Wash has been taken private by Leonard Green & Partners in a $3.1 billion deal, ending its Nasdaq listing. Shareholders received $7.00 per share.

T1 Energy Surges on Hedge Fund Stake and Short Seller Allegations
Markets Daniel Marsh

T1 Energy Surges on Hedge Fund Stake and Short Seller Allegations

T1 Energy shares surged 17% as a hedge fund disclosed a new stake, while a short-seller report questioned the company's tax-credit eligibility and China-linked supply chain.

FXI
Biogen Closes Apellis Takeover; Focus Shifts to Syfovre Milestones
Markets Daniel Marsh

Biogen Closes Apellis Takeover; Focus Shifts to Syfovre Milestones

Biogen has completed its $5.6 billion acquisition of Apellis Pharmaceuticals, delisting APLS from Nasdaq. Shareholders received $41 per share plus a contingent value right linked to Syfovre sales targets.

BIIB APLS
NextNRG Shares Retreat After Doubling on Record April Sales
Markets Daniel Marsh

NextNRG Shares Retreat After Doubling on Record April Sales

NextNRG Inc. shares retreated in premarket after doubling on record April revenue of $9.4 million, as cash concerns and Nasdaq listing pressure weighed on investor sentiment.

GCL Global Shares Surge on $10M ADATA Investment, Nasdaq Compliance Looms
Markets Daniel Marsh

GCL Global Shares Surge on $10M ADATA Investment, Nasdaq Compliance Looms

GCL Global Holdings shares surged after ADATA invested $10M in its 4Divinity unit, but the stock still trades below Nasdaq's $1 minimum bid price, facing a Sept. 14 deadline.

GCL
Silexion Advances Pancreatic Cancer Trial Amid Cash Concerns
Markets Daniel Marsh

Silexion Advances Pancreatic Cancer Trial Amid Cash Concerns

Silexion Therapeutics progresses its SIL204 pancreatic cancer drug into clinical trials, but a shrinking cash position and recent stock decline highlight funding challenges.

SLXN
AEP Texas Resolves San Angelo Blackout Amid Rising Texas Demand
Markets Daniel Marsh

AEP Texas Resolves San Angelo Blackout Amid Rising Texas Demand

AEP Texas restored power to nearly all Tom Green County customers after a substation failure cut service to 7,800 in San Angelo. The outage comes as AEP faces scrutiny over Texas demand and a $78B capital plan.

AEP
InMed Stock Retreats After 135% Merger Rally; Deal Dilution Weighs
Markets Daniel Marsh

InMed Stock Retreats After 135% Merger Rally; Deal Dilution Weighs

InMed Pharmaceuticals shares fell 14.4% in pre-market trading Wednesday, giving back some of Tuesday's 135% surge on news of an all-stock merger with Mentari Therapeutics and a $290 million private placement.

INM LLY